These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

344 related items for PubMed ID: 9916717

  • 1. Suppression of host immune response by the core protein of hepatitis C virus: possible implications for hepatitis C virus persistence.
    Large MK, Kittlesen DJ, Hahn YS.
    J Immunol; 1999 Jan 15; 162(2):931-8. PubMed ID: 9916717
    [Abstract] [Full Text] [Related]

  • 2. Expression and immune response to hepatitis C virus core DNA-based vaccine constructs.
    Tokushige K, Wakita T, Pachuk C, Moradpour D, Weiner DB, Zurawski VR, Wands JR.
    Hepatology; 1996 Jul 15; 24(1):14-20. PubMed ID: 8707253
    [Abstract] [Full Text] [Related]

  • 3. Genetic immunization of wild-type and hepatitis C virus transgenic mice reveals a hierarchy of cellular immune response and tolerance induction against hepatitis C virus structural proteins.
    Satoi J, Murata K, Lechmann M, Manickan E, Zhang Z, Wedemeyer H, Rehermann B, Liang TJ.
    J Virol; 2001 Dec 15; 75(24):12121-7. PubMed ID: 11711603
    [Abstract] [Full Text] [Related]

  • 4. Inhibitory effects of chronic ethanol consumption on cellular immune responses to hepatitis C virus core protein are reversed by genetic immunizations augmented with cytokine-expressing plasmids.
    Geissler M, Gesien A, Wands JR.
    J Immunol; 1997 Nov 15; 159(10):5107-13. PubMed ID: 9366440
    [Abstract] [Full Text] [Related]

  • 5. A novel combined vaccine candidate containing epitopes of HCV NS3, core and E1 proteins induces multi-specific immune responses in BALB/c mice.
    Zeng R, Li G, Ling S, Zhang H, Yao Z, Xiu B, He F, Huang R, Wei L.
    Antiviral Res; 2009 Oct 15; 84(1):23-30. PubMed ID: 19646486
    [Abstract] [Full Text] [Related]

  • 6. Lethality in mice infected with recombinant vaccinia virus expressing hepatitis C virus core protein.
    Zhang H.
    Hepatobiliary Pancreat Dis Int; 2003 Aug 15; 2(3):374-82. PubMed ID: 14599943
    [Abstract] [Full Text] [Related]

  • 7. Evasion of host immune surveillance by hepatitis C virus: potential roles in viral persistence.
    Moorman JP, Joo M, Hahn YS.
    Arch Immunol Ther Exp (Warsz); 2001 Aug 15; 49(3):189-94. PubMed ID: 11478392
    [Abstract] [Full Text] [Related]

  • 8. Induction of hepatitis C virus-specific cytotoxic T lymphocytes in mice by an intrahepatic inoculation with an expression plasmid.
    Kamei A, Tamaki S, Taniyama H, Takamura S, Nishimura Y, Kagawa Y, Uno-Furuta S, Kaito M, Kim G, Toda M, Matsuura Y, Miyamura T, Adachi Y, Yasutomi Y.
    Virology; 2000 Jul 20; 273(1):120-6. PubMed ID: 10891414
    [Abstract] [Full Text] [Related]

  • 9. Enhancement of cellular and humoral immune responses to hepatitis C virus core protein using DNA-based vaccines augmented with cytokine-expressing plasmids.
    Geissler M, Gesien A, Tokushige K, Wands JR.
    J Immunol; 1997 Feb 01; 158(3):1231-7. PubMed ID: 9013964
    [Abstract] [Full Text] [Related]

  • 10. Virus-specific T-cell responses associated with hepatitis C virus (HCV) persistence in the liver after apparent recovery from HCV infection.
    Quiroga JA, Llorente S, Castillo I, Rodríguez-Iñigo E, López-Alcorocho JM, Pardo M, Carreño V.
    J Med Virol; 2006 Sep 01; 78(9):1190-7. PubMed ID: 16847959
    [Abstract] [Full Text] [Related]

  • 11. Relation between viral fitness and immune escape within the hepatitis C virus protease.
    Söderholm J, Ahlén G, Kaul A, Frelin L, Alheim M, Barnfield C, Liljeström P, Weiland O, Milich DR, Bartenschlager R, Sällberg M.
    Gut; 2006 Feb 01; 55(2):266-74. PubMed ID: 16105887
    [Abstract] [Full Text] [Related]

  • 12. Different doses of adenoviral vector expressing IL-12 enhance or depress the immune response to a coadministered antigen: the role of nitric oxide.
    Lasarte JJ, Corrales FJ, Casares N, López-Díaz de Cerio A, Qian C, Xie X, Borrás-Cuesta F, Prieto J.
    J Immunol; 1999 May 01; 162(9):5270-7. PubMed ID: 10228002
    [Abstract] [Full Text] [Related]

  • 13. DNA prime-canarypox boost with polycistronic hepatitis C virus (HCV) genes generates potent immune responses to HCV structural and nonstructural proteins.
    Pancholi P, Liu Q, Tricoche N, Zhang P, Perkus ME, Prince AM.
    J Infect Dis; 2000 Jul 01; 182(1):18-27. PubMed ID: 10882577
    [Abstract] [Full Text] [Related]

  • 14. Whole recombinant yeast-based immunotherapy induces potent T cell responses targeting HCV NS3 and Core proteins.
    Haller AA, Lauer GM, King TH, Kemmler C, Fiolkoski V, Lu Y, Bellgrau D, Rodell TC, Apelian D, Franzusoff A, Duke RC.
    Vaccine; 2007 Feb 09; 25(8):1452-63. PubMed ID: 17098335
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Expression and immune response to hepatitis C virus core gene combined hepatitis B virus core gene with two multiple cloning sites vector].
    Deng T, Fan G, Chen T, Chen N, Hu D, Wang M, Jia K.
    Zhonghua Yi Xue Za Zhi; 2002 Jan 25; 82(2):77-80. PubMed ID: 11953132
    [Abstract] [Full Text] [Related]

  • 17. IL-12 delivery from recombinant vaccinia virus attenuates the vector and enhances the cellular immune response against HIV-1 Env in a dose-dependent manner.
    Gherardi MM, Ramirez JC, Rodríguez D, Rodríguez JR, Sano G, Zavala F, Esteban M.
    J Immunol; 1999 Jun 01; 162(11):6724-33. PubMed ID: 10352291
    [Abstract] [Full Text] [Related]

  • 18. Induction of potent cellular immune response in mice by hepatitis C virus NS3 protein with double-stranded RNA.
    Jin B, Wang RY, Qiu Q, Sugauchi F, Grandinetti T, Alter HJ, Shih JW.
    Immunology; 2007 Sep 01; 122(1):15-27. PubMed ID: 17451465
    [Abstract] [Full Text] [Related]

  • 19. Activation of refractory T cell responses against hepatitis C virus core protein by ablation of interfering hydrophobic domains.
    Andersson HA, Singh RA, Barry MA.
    Mol Ther; 2006 Feb 01; 13(2):338-46. PubMed ID: 16242998
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.